Literature DB >> 495695

The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice.

M H van Rijswijk, C W van Heusden.   

Abstract

Alterations in affinity of amyloid for Congo red after incubation of tissue sections with potassium permanganate, as described by Wright el al, were studied. The affinity of amyloid for Congo red after incubation with potassium permanganate did not change in patients with myeloma-associated amyloidosis, familial amyloidotic polyneuropathy, medullary carcinoma of the thyroid, pancreatic island amyloid, and cerebral amyloidosis. Affinity for Congo red was lost after incubation with potassium permanganate in tissue sections from patients with secondary amyloidosis and amyloidosis complicating familial Mediterranean fever (consisting of amyloid AA). Patients with primary amyloidosis could be divided into two groups, one with potassium-permanganate--sensitive and one with potassium-permanganate--resistant amyloid deposits. These two groups correlated with the clinical classification in typical organ distribution (presenting with nephropathy) and atypical organ distribution (presenting with cardiomyopathy, nephropathy, and glossopathy) and the expected presence of amyloid AA or amyloid AL. Potassium permanganate sensitivity seems to be restricted to amyloid AA. The potassium permanganate method can be important in dividing the major forms of generalized amyloidosis in AA amyloid and non-AA amyloid. This can be used for differentiating early stages of the disease and cases otherwise difficult to classify. It is important to define patient groups properly, especially in evaluating the effect of therapeutic measures. (Am J Pathol 97:43--58, 1979).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 495695      PMCID: PMC2042379     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  Dimethylsulphoxide in amyloidosis.

Authors:  M H van Rijswijk; A J Donker; L Ruinen
Journal:  Lancet       Date:  1979-01-27       Impact factor: 79.321

2.  Effect of a single dose of dimethyl sulphoxide on renal amyloidosis.

Authors:  M Ravid; I K Keizman; E Sohar
Journal:  Lancet       Date:  1977-04-02       Impact factor: 79.321

3.  Prolonged colchicine treatment in four patients with amyloidosis.

Authors:  M Ravid; M Robson; I Kedar
Journal:  Ann Intern Med       Date:  1977-11       Impact factor: 25.391

4.  Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils.

Authors:  P Westermark; J B Natvig; R F Anders; K Sletten; G Husby
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

5.  Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.

Authors:  J R Wright; E Calkins; R L Humphrey
Journal:  Lab Invest       Date:  1977-03       Impact factor: 5.662

6.  Variation with age and disease of an amyloid A protein-related serum component.

Authors:  C J Rosenthal; E C Franklin
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

7.  Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy.

Authors:  P P Costa; A S Figueira; F R Bravo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

8.  Identification and characterization of different amyloid fibril proteins in tissue sections.

Authors:  G G Cornwell; G Husby; P Westermark; J B Natvig; T E Michaelsen; B Skogen
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

9.  Characterization of an amyloid fibril protein from senile cardiac amyloid.

Authors:  P Westermark; J B Natvig; B Johansson
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

10.  Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid.

Authors:  K Sletten; P Westermark; J B Natvig
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more
  24 in total

1.  Isolated ectopic lung uptake of technetium 99m methylene diphosphonate on bone scintigraphy in primary amyloidosis.

Authors:  S T Zwas; O Shpilberg; M Huszar; J Rozenman
Journal:  Eur J Nucl Med       Date:  1990

Review 2.  Diffuse mesenteric amyloidosis.

Authors:  V Mohan; J A Kemp; H E Lewine; M Rabin; M L Goldstein; F A Farraye
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

3.  Diagnosis of the type of amyloid in paraffin wax embedded tissue sections using antisera against human and animal amyloid proteins.

Authors:  C A van de Kaa; P R Hol; J Huber; R P Linke; C J Kooiker; E Gruys
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

4.  Amyloid neuropathy: immunocytochemical localization of intra- and extracellular immunoglobulin light chains.

Authors:  C Sommer; J M Schröder
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Juvenile rheumatoid arthritis with amyloid goiter: report of a case with review of the literature.

Authors:  A Srivastava; M Baxi; S Yadav; A Agarwal; R K Gupta; S K Misra; A Mithal
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

6.  Amyloid (AL) in an octogenarian diagnosed by abdominal wall fat biopsy.

Authors:  W J Mallinson; O J Corrado; S R Milkins
Journal:  Postgrad Med J       Date:  1987-02       Impact factor: 2.401

Review 7.  Behçet's disease associated with amyloidosis.

Authors:  M Chiba; Y Inoue; H Arakawa; O Masamune; M Ohkubo
Journal:  Gastroenterol Jpn       Date:  1987-08

Review 8.  Dubious effect of dimethylsulphoxide (DMSO) therapy on amyloid deposits and amyloidosis.

Authors:  E Gruys; R J Sijens; W J Biewenga
Journal:  Vet Res Commun       Date:  1981-09       Impact factor: 2.459

9.  Cytochemistry of brain amyloid in adult dementia.

Authors:  R M Torack; R G Lynch
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

Review 10.  Amyloid goiter: two cases and a review of the literature.

Authors:  Levent Yildiz; Mehmet Kefeli; Behiye Kose; Sancar Baris
Journal:  Ann Saudi Med       Date:  2009 Mar-Apr       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.